文献速递慢性静脉疾病

专用静脉支架治疗急性和慢性髂股静脉疾病中支架移位发生率的系统综述

A Systematic Review on the Incidence of Stent Migration in the Treatment of Acute and Chronic Iliofemoral Disease Using Dedicated Venous Stents.
PubMed 文献 · Ann Vasc Surg · 2022-01-18

支架移位发生6例(占患者0.17%),其中3例涉及闭孔型支架、1例涉及混合设计支架。12个月一期和二期支架通畅率汇总分别为73.8%和91.5%。作者认为支架移位率低,但可能归因于报告不足,需进一步研究以可靠确定真实发生率。

要点

  • 专用静脉支架治疗髂股静脉疾病,支架移位发生6例(占患者0.17%)。
  • 6例移位中3例涉及闭孔型支架、1例涉及混合设计支架。
  • 汇总12个月一期和二期支架通畅率分别为73.8%和91.5%。

核心结论

  • 使用专用静脉支架进行髂股静脉支架置入与低支架移位率相关,但这可能归因于报告不足。
  • 需要采用特定监测方案的进一步研究来可靠确定支架移位的真实发生率。

研究设计与样本

  • 系统综述,检索MEDLINE和Embase数据库中2012年1月至2021年12月发表的文献。
  • 共使用10种专用静脉支架品牌。

主要发现

  • 支架移位发生6例(占患者0.17%),其中3例涉及闭孔型支架、1例涉及混合设计支架。
  • 急性深静脉血栓患者12个月一期通畅率范围为86%至88%,二期通畅率为96%。
  • 慢性疾病队列中,一期和二期通畅率范围分别为59%至94%和87%至100%。
  • 汇总12个月一期和二期支架通畅率分别为73.8%和91.5%。

局限性

  • 支架移位率低可能归因于报告不足。
  • 需要采用特定监测方案的进一步研究来可靠确定支架移位的真实发生率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This systematic review investigated the incidence of stent migration in patients with acute and chronic deep venous iliofemoral disease who were treated with dedicated venous stents. Procedural approaches, clinical and stent patency outcomes, and other complications are described. METHODS: MEDLINE and Embase were searched for literature published from January, 2012 to December, 2021. Evidence on the study population and procedural characteristics, and outcomes related to symptomatic changes, health-related quality of life, stent patency and complications was presented. RESULTS: Fourty-two studies were identified from 857 articles found through the database searches. Five-hundred seventy acute deep vein thrombosis patients and 2,859 chronic disease patients were included. Ten dedicated venous stent brands were employed. There were six episodes of stent migration (0.17% of patients) of which three involved a closed-cell stent and one involved a hybrid-design stent. The 12-month primary patency rate in patients with acute deep vein thrombosis ranged from 86 to 88%, whilst secondary patency was 96%. Amongst the chronic-disease cohort the primary and secondary patency were noted to range from 59 to 94%, and 87 to 100%, respectively. The pooled 12-month primary and secondary stent patency rates were 73.8% and 91.5%, respectively. CONCLUSIONS: Iliofemoral stenting using dedicated venous stents is associated with a low rate of stent migration although this may be due to a lack of reporting. Further research with specific surveillance protocols is necessary to reliably determine the true incidence of stent migration.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Badesha AS, Siddiqui MM, Bains BRS, et al. A Systematic Review on the Incidence of Stent Migration in the Treatment of Acute and Chronic Iliofemoral Disease Using Dedicated Venous Stents. Ann Vasc Surg. 2022. PMID: 35051587. doi:10.1016/j.avsg.2021.12.084

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。